What makes cells grow larger and how do they do it? Renal hypertrophy revisited

Experimental Nephrology

Volumn 7, Issue 4, 1999, Pages 273-283

  Preisig, Patricia ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Ammonia; Cell cycle; Cell growth; Growth factors; Hyperplasia; Hypertrophy; In vitro models; In vivo models; Kidney; TGF

Indexed keywords

GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; CELL CYCLE G1 PHASE; CELL GROWTH; CELL HYPERPLASIA; CELL SIZE; ENZYME ACTIVITY; IN VIVO STUDY; KIDNEY DEVELOPMENT; KIDNEY HYPERTROPHY; KIDNEY TUBULE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 0032771641     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020614     Document Type: Review

References (73)

1. Zetterberg A, Larsson O, Wiman KG: What is the restriction point? Curr Biol 1995;7:835-842.
2. Oliver J: New directions in renal morphology: A method, its results and its future. Harvey Lect 1944;40:102-155.
3. Bouby N, Bankir L, Trinh-Trang-Tan MM, Minuth WW, Kriz W: Selective ADH-induced hypertrophy of the medullary thick ascending limb in Brattleboro rats. Kidney Int 1985;28: 456-466.
4. Liu B, Preisig PA: Compensatory renal hypertrophy (CRH) is mediated by both cell cycle-dependent and -independent growth processes (abstract). J Am Soc Nephrol 1998;9:444.
5. Liu B, Preisig PA: Renal hypertrophy following uninephrectomy (Unx) is associated with activation of cdk2/cyclin E, but not cdk4/cyclin D1 kinase (abstract). J Am Soc Nephrol 1997;8: 424.
6. Huang HC, Preisig PA: Cyclin D kinase is activated in all diabetic renal growth, while cyclin E kinase determines whether the growth pattern will be hyperplasia or hypertrophy (abstract). J Am Soc Nephrol 1998;9:440.
7. Lotspeich WD: Renal hypertrophy in metabolic acidosis and its relation to ammonia excretion. Am J Physiol 1965;208:1135-1142.
8. Seyer-Hansen K: Renal hypertrophy in experimental diabetes mellitus. Kidney Int 1983;23: 643-646.
9. Seyer-Hansen K: Renal hypertrophy in experimental diabetes: A comparison to compensatory hypertrophy. Diabetologia 1978;14:325-328.
10. Seyer-Hansen K: Renal hypertrophy in experimental diabetes: Relation to severity of diabetes. Diabetologia 1977;13:141-143.
11. Seyer-Hansen K: Renal hypertrophy in streptozotocin-diabetic rats. Clin Sci Mol Med 1976; 51:551-555.
12. Seyer-Hansen K, Hansen J, Gunderson HJG: Renal hypertrophy in experimental diabetes. Diabetologia 1980;18:501-505.
13. 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologia 1983;25: 280-287.
14. Spargo B: Kidney changes in hypokalemic alkalosis in the rat. J Lab Clin Med 1954;43:802-814.
15. Toback FG, Ordonez NG, Bortz SL, Spargo B: Zonal changes in renal structure and phospholipid metabolism in potassium-deficients rats. Lab Invest 1976;34:115-124.
16. Ordonez NG, Toback FG, Aithal HN, Spargo B: Zonal changes in renal structure and phospholipid metabolism during reversal of potassium depletion nephropathy. Lab Invest 1977; 36:33-47.
17. Davison JM, Lindheimer MD: Changes in renal haemodynamics and kidney weight during pregnancy in the unanesthetized rat. J Physiol 1980;301:129-136.
18. Matthews BF: Growth of the maternal kidneys in pregnant mice. Proc J Physiol 1977;273: 84P.
19. Baylis C, Rennke HG: Renal hemodynamics and glomerular morphology in repetitively pregnant aging rats. Kidney Int 1985;28:140-145.
20. Baylis C: Glomerular filtration rate in normal and abnormal pregnancies. Semin Nephrol 1999;19:133-139.
21. Fine L: The biology of renal hypertrophy. Kidney Int 1986;29:619-634.
22. Bouby N, Trinh-Trang-Tan MM, Laouari D, et al: Role of the urinary concentrating process in the renal effects of high protein intake. Kidney Int 1988;34:4-12.
23. WAF1/CIP1 is increased in experimental diabetic nephropathy: Potential role in glomerular hypertrophy. J Am Soc Nephrol 1998;9:986-993.
24. Ziyadeh FN, Goldfarb S, Kern EFO: Diabetic nephropathy: Metabolic and biochemical mechanisms; in Brenner BM, Stein JH (eds): Contemporary Issues in Nephrology. New York, Churchill Livingstone, 1989, pp 87-113.
25. Abboud HE: Growth factors and diabetic nephropathy: An overview. Kidney Int 1997;52: S3-S6.
26. Ziyadeh FN, Han DC: Involvement of transforming growth factor-β and its receptors in the pathogenesis of diabetic nephropathy. Kidney Int 1997;52:S7-S11.
27. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 1990;259:F704-F714.
28. Wolf G, Neilson EG: Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 1990;259: F768-F777.
29. Wolf G, Neilson EG, Goldfarb S, Ziyadeh FN: The influence of glucose concentration on angiotensin II-induced hypertrophy of proximal tubular cells in culture. Biochem Biophys Res Commun 1991;176:902-909.
30. Franch HA, Shay JW, Alpern RJ, Preisig PA: Involvement of pRB family in TGFβ-dependent epithelial cell hypertrophy. J Cell Biol 1995;129:245-254.
31. Fine LG, Badie-Dezfooly B, Lowe AG, Hamzeh A, Wells J, Salehmoghaddam S: Stimulation of Na/H antiport is an early event in hypertrophy of renal proximal tubular cells. Proc Natl Acad Sci USA 1985;82:1736-1740.
32. + antiport activity. Proc Natl Acad Sci USA 1985;82:6163-6166.
33. 4Cl. J Clin Invest 1989;84:1767-1779.
34. 4Cl-induced hypertrophy is mediated by weak base effects and is independent of cell cycle processes. Am J Physiol 1996;270:C932-C938.
35. 4CI in cultured renal proximal tubule cells. J Am Soc Nephrol 1996;7:73-80.
36. Kip1. Kidney 1996;50:2112-2119.
37. 1 receptor. Nephrol Dial Transplant 1993;8: 128-133.
38. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose stimulates TGFβ gene expression and bioactivity in proximal tubule. Kidney Int 1992;41:107-114.
39. Wolf G, Ziyadeh FN: The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 1997;29:153-163.
40. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 1993;92:1366-1372.
41. Wolf G, Ziyadeh FN, Zahner G, Stahl RAK: Angiotensin II-stimulated expression of transforming growth factor-beta in renal proximal tubule cells: Attenuation after stable transfection with the c-mas oncogene. Kidney Int 1995; 48:1818-1827.
42. Preisig PA, Franch HA: Renal epithelial cell hyperplasia and hypertrophy. Semin Nephrol 1995;15:327-340.
43. Shankland SJ: Cell-cycle control and renal disease. Kidney Int 1997;52:294-308.
44. Preisig PA: Renal hypertrophy and hyperplasia; in Selden DW, Giebisch G (eds): The Kidney: Physiology and Pathophysiology, in press.
45. Sherr CJ: Mammalian G1 cyclins and cell cycle progression. Proc Assoc Am Phys 1995;107: 181-186.
46. Terada Y, Tatsuka M, Jinno S, Okayama H: Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 1995;376:358-362.
47. Matsuoka M, Kato JY, Fisher RP, Morgan DO, Sherr CJ: Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol Cell Biol 1994;14:7265-7275.
48. Fisher RP, Morgan DO: A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 1994;78:713-724.
49. Fesquet D, Labbe JC, Derancourt J, et al: The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr 161 and its homologues. EMBO J 1993;12:3111-3121.
50. Gu Y, Rosenblatt J, Morgan DO: Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tvr15. EMBO J 1992;11:3995-4005.
51. Jinno S, Suto K, Nagata A, et al: Cdc25A is a novel phosphatasc functioning early in the cell cycle. EMBO J 1994;13:1549-1556.
52. 1/S transition. EMBO J 1994;13:4302-4310.
53. Kitagawa M, Higashi H, Jung HK, et al: The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J 1997;15: 7060-7069.
54. Lundberg AS, Weinberg RA: Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 1998;18: 753-761.
55. Weintraub SJ, Prater CA, Dean DC: Retinoblastoma protein switches the E2F site from a positive to negative element. Nature 1992;358: 259-261.
56. 1 cyclin-dependent kinases. Genes Dev 1995;9:1149-1163.
57. Franch HA, Alpern RJ, Preisig PA: TGFβ converts EGF-induced hyperplasia to hypertrophy by inhibiting cdk2/cyclin E kinase activity (abstract). J Am Soc Nephrol 1995;6:767.
58. Liu B, Preisig PA: TGFβ-mediated conversion of EGF-induced hyperplasia to hypertrophy involves cyclin E, but not cyclin D kinase regulation, and is dependent on cells being in a confluent state (abstract). J Am Soc Nephrol 1996; 7:1661.
59. 1 expression determines response to angiotensin II. J Clin Invest 1992;90:456-461.
60. Walsh-Reitz MM, Toback FG: Kidney epithelial cell growth is stimulated by lowering extracellular potassium concentration. Am J Physiol 1983;244:C429-C432.
61. Tovbin D, Franch HA, Alpern RJ, Preisig PA: Media acidification inhibits TGFβ-mediated growth suppression in cultured rabbit proximal tubule cells. Proc Assoc Am Phys 1997;109: 572-579.
62. Franch HA, Curtis PV, Mitch WE: Mechanisms of renal tubular cell hypertrophy: Mitogen-induced suppression of proteolysis. Am J Physiol 1997;273:C843-C851.
63. Ling H, Vamvakas S, Schaefer L, Schnittler HJ, Schaefer RM, Heidland A: Angiotensin-II-induced cell hypertrophy: Potential role of impaired proteolytic activity in cultured LLC-PK1 cells. Nephrol Dial Transplant 1995;10: 1305-1312.
64. Hammerman MR, O'Shea M, Miller SB: Role of growth factors in regulation of renal growth. Annu Rev Physiol 1993;55:305-321.
65. Luyckx VA, Brenner BM: The renal consequences of progressive nephron loss; in Selden DW, Giebisch G (eds): The Kidney: Physiology and Pathophysiology, in press.
66. Park SK, Kang SK, Lee DY, Kang MJ, Kim SH, Koh GY: Temporal expressions of cyclins and cyclin-dependent kinases during renal development and compensatory growth. Kidney Int 1997;51:762-769.
67. Shankland SJ, Al'Douahji M: Cell cycle regulatory proteins in glomerular disease. Exp Nephrol 1999;7:201-206.
68. Anderson PW, Do YS, Hsueh WA: Angiotensin II causes mesangial cell hypertrophy. Hypertension 1993;21:29-35.
69. Wolf G, Sharma K, Chen Y, Erickscn M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 1992;52:647-656.
70. Wolf G, Ziyadeh FN, Thaiss F, Zahner G, Stahl RAK: High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: Relationship to hypertrophy. Am J Physiol 1997;42:F348-F356.
71. Shankland SJ, Hamel PA, Scholey JW: Phosphorylation of retinoblastoma protein (pRB) in glomeruli of normal, diabetic (DM), and renalablated rats (REM) (abstract). J Am Soc Nephrol 1994;5:701.
72. Kip1 in diabetic db/db mouse: Role of hyperglycemia. Kidney Int 1998;53:869-879.
73. 1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk2 activation and retinoblastoma protein phosphorylation. Kidney Int 1997;51: 1228-1236.